carvedilol has been researched along with Ventricular Fibrillation in 6 studies
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Carvedilol, a nonselective beta-blocker, is widely used to prevent ventricular arrhythmias after myocardial infarction (MI)." | 7.75 | Carvedilol ameliorates the decreases in connexin 43 and ventricular fibrillation threshold in rats with myocardial infarction. ( Chen, J; He, B; Hu, X; Jiang, H; Lu, Z; Wen, H; Zhao, D, 2009) |
| " Carvedilol, a nonselective beta-blocker, is widely used to prevent ventricular arrhythmias after myocardial infarction (MI)." | 3.75 | Carvedilol ameliorates the decreases in connexin 43 and ventricular fibrillation threshold in rats with myocardial infarction. ( Chen, J; He, B; Hu, X; Jiang, H; Lu, Z; Wen, H; Zhao, D, 2009) |
| "Carvedilol pretreatment followed by epinephrine treatment reduced early postresuscitation ventricular ectopy (116 +/- 147 vs 834 +/- 380, P < ." | 1.33 | Carvedilol mitigates adverse effects of epinephrine during cardiopulmonary resuscitation. ( Fang, X; Huang, L; Sun, S; Tang, W; Weil, MH, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruwald, AC | 1 |
| Gislason, GH | 1 |
| Vinther, M | 1 |
| Johansen, JB | 1 |
| Nielsen, JC | 1 |
| Philbert, BT | 1 |
| Torp-Pedersen, C | 1 |
| Riahi, S | 1 |
| Jøns, C | 1 |
| Wen, H | 1 |
| Jiang, H | 1 |
| Lu, Z | 1 |
| He, B | 1 |
| Hu, X | 1 |
| Chen, J | 1 |
| Zhao, D | 1 |
| He, L | 1 |
| Xiao, J | 1 |
| Fu, H | 1 |
| Du, G | 1 |
| Xiao, X | 1 |
| Zhang, C | 1 |
| Gu, Y | 1 |
| Ma, Y | 1 |
| Huang, L | 1 |
| Weil, MH | 1 |
| Sun, S | 1 |
| Tang, W | 1 |
| Fang, X | 1 |
| Hohnloser, SH | 1 |
| Dorian, P | 1 |
| Roberts, R | 1 |
| Gent, M | 1 |
| Israel, CW | 1 |
| Fain, E | 1 |
| Champagne, J | 1 |
| Connolly, SJ | 1 |
| Xie, J | 1 |
| Dunn, A | 1 |
| Tsikouris, JP | 1 |
| Sun, Y | 1 |
| Fan, C | 1 |
| Kluger, J | 1 |
| Chow, MS | 1 |
| White, CM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| [NCT00257959] | Phase 4 | 400 participants | Interventional | 2001-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for carvedilol and Ventricular Fibrillation
5 other studies available for carvedilol and Ventricular Fibrillation
| Article | Year |
|---|---|
Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Carvedilol; Death, Sudden, Cardiac; Defibrillators, Implantable; | 2018 |
Carvedilol ameliorates the decreases in connexin 43 and ventricular fibrillation threshold in rats with myocardial infarction.
Topics: Animals; Blotting, Western; Carbazoles; Carvedilol; Connexin 43; Disease Models, Animal; Fluorescent | 2009 |
Effect of oxidative stress on ventricular arrhythmia in rabbits with adriamycin-induced cardiomyopathy.
Topics: Animals; Anti-Arrhythmia Agents; Antibiotics, Antineoplastic; Carbazoles; Cardiomyopathies; Carvedil | 2012 |
Carvedilol mitigates adverse effects of epinephrine during cardiopulmonary resuscitation.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Animals; Carbazoles; Cardiopulmonary Resuscitation; Car | 2005 |
A placebo controlled evaluation of the antifibrillatory effects of carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Heart Rate; Propanolam | 2001 |